Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke

Intravenous administration of fibrinolytic drugs, such as recombinant tissue plasminogen activator (rtPA) is the standard treatment of acute thrombotic diseases. However, current fibrinolytics exhibit limited ...

Source: Journal of Nanobiotechnology - January 3, 2024 Category: Nanotechnology Authors: Martina Migliavacca, Clara Correa-Paz, Mar ía Pérez-Mato, Patrick-Brian Bielawski, Issan Zhang, Pauline Marie, Pablo Hervella, Marina Rubio, Dusica Maysinger, Denis Vivien, Pablo del Pino, Beatriz Pelaz, Ester Polo and Francisco Campos Tags: Research Source Type: research